LITS - MEI Pharma, Inc.
1.18
0 0%
Share volume: 397,835
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.18
0.00
0.00%
Summary score
21%
Profitability
25%
Dept financing
3%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2014 - 2018
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.45%
Return on assets
-6.39%
Return on sales
-1084.51%
Return on invested capital
30.45%
Total debt ratio
12.38%
Debt ratio change over timeo
0%
Current Ratio
10.21%
Quick Ratio
0%
Cash Position Ratio
1.97%
Short-term ratios 2017 - 2018
The data are presented for the financials results of the quarters of the last year.
Return on equity
-15.66%
Return on assets
-14.21%
Return on sales
-1812.72%
Return on invested capital
145.01%
Total debt ratio
10.49%
Debt ratio change over timeo
0%
Current Ratio
9.65%
Quick Ratio
0%
Cash Position Ratio
1.52%
Last quarter ratios 2018
The data are presented for the financials results of the last quarter.
Return on equity
-18.07%
Return on assets
-16.19%
Return on sales
-1398.15%
Return on invested capital
143.57%
Total debt ratio
11.99%
Debt ratio change over time
0%
Current Ratio
8.26%
Quick Ratio
0%
Cash Position Ratio
1.38%
Performance ratios (change over 4 years) 2014 - 2018
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LITS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -7.45% | 2.1% | 2.44% | 31.25% |
| Return on assets | -6.39% | 2.93% | 3.38% | 3.83% |
| Return on sales | -1084.51% | 21.3% | 26.79% | 36.93% |
| Return on invested capital | 30.45% | 2.05% | 3.53% | 4.31% |
| Profitability | 25% | 37% | 45% | 79% |
| Total debt ratio | 12.38% | 65.37% | 53.79% | 91.96% |
| Debt ratio change over time | 0% | 0% | -5.66% | 599.68% |
| Dept financing | 3% | 18% | 15% | 50% |
| Current Ratio | 9.65% | 1.37% | 1.41% | 1.33% |
| Quick Ratio | 0% | 1.01% | 1.1% | 1.21% |
| Cash Position Ratio | 1.52% | 0.32% | 0.52% | 0.57% |
| Liquididy | 50% | 24% | 38% | 34% |
| Short-term ratios | LITS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -15.66% | 1.24% | -0.12% | 33.83% |
| Return on assets | -14.21% | 3.04% | 3.13% | 3.81% |
| Return on sales | -1812.72% | 22.59% | 24.83% | 35.63% |
| Return on invested capital | 145.01% | 1.04% | 0.33% | 4.59% |
| Profitability | 25% | 37% | 38% | 76% |
| Total debt ratio | 10.49% | 68.11% | 56.69% | 92.25% |
| Debt ratio change over time | 0% | 0% | -5.66% | 599.68% |
| Dept financing | 3% | 18% | 15% | 50% |
| Current Ratio | 9.65% | 1.37% | 1.41% | 1.33% |
| Quick Ratio | 0% | 1.01% | 1.1% | 1.21% |
| Cash Position Ratio | 1.52% | 0.32% | 0.52% | 0.57% |
| Liquididy | 50% | 30% | 35% | 38% |